This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parker, T. S. Articles by Rubin, A. L. Search for Related Content PubMed PubMed Citation Articles by Parker, T. S. Articles by Rubin, A. L.

 Previous Article  |  Next Article 

Infect. Immun., 01 1995, 253-258, Vol 63, No. 1
Copyright © 1995, American Society for Microbiology

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood

TS Parker, DM Levine, JC Chang, J Laxer, CC Coffin and AL Rubin
Rogosin Institute, New York Hospital-Cornell Medical Center, New York 10021.

We have tested hypotheses relating lipoprotein structure to function as measured by the relative ability to neutralize endotoxin by comparing natural human lipoproteins, a chemically defined form of reconstituted high-density lipoprotein (R-HDL), and a lipid emulsion (Intralipid). The human whole-blood system was used as an in vitro model of lipopolysaccharide (LPS) binding protein and CD14-dependent activation of cytokine production. When lipoproteins were compared on the basis of protein content, R-HDL was most effective in reducing tumor necrosis factor alpha (TNF-alpha) production followed in order by very low density lipoprotein, low-density lipoprotein, Intralipid, and natural HDL. However, when these particles were compared by protein, phospholipid, cholesterol, or triglyceride content by stepwise linear regression analysis, only phospholipid was correlated to effectiveness (r2 = 0.873; P < 0.0001). Anti-CD14 monoclonal antibodies MY4 and 3C10 inhibited LPS binding protein and CD14-dependent activation of TNF- alpha production by LPS at LPS concentrations up to approximately 1.0 ng/ml. R-HDL (2 mg of protein per ml) blocked TNF-alpha production by LPS from both smooth- and rough-type gram-negative bacteria at concentrations up to 100 ng of LPS per ml but had little effect on heat- killed gram-positive Staphylococcus aureus and no effect on other LPS- independent stimuli tested. These results support our hypothesis that LPS is neutralized by binding to phospholipid on the surface of R-HDL and demonstrate that R-HDL is a potent inhibitor of the induction of TNF-alpha by LPS from both rough- and smooth-form gram-negative bacteria in whole human blood.

This article has been cited by other articles:

• Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, ff. M., Da Silva, N. F., Khanolkar, M., Evans, M., Harte, A. L., Kumar, S. (2007). Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292: E740-E747 [Abstract] [Full Text]  
• Thaveeratitham, P., Plengpanich, W., Naen-Udorn, W., Patumraj, S., Khovidhunkit, W. (2007). Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro. Innate Immunity 13: 58-64 [Abstract]  
• Thompson, P. A., Kitchens, R. L. (2006). Native High-Density Lipoprotein Augments Monocyte Responses to Lipopolysaccharide (LPS) by Suppressing the Inhibitory Activity of LPS-Binding Protein. J. Immunol. 177: 4880-4887 [Abstract] [Full Text]  
• Courtney, H. S., Zhang, Y.-M., Frank, M. W., Rock, C. O. (2006). Serum Opacity Factor, a Streptococcal Virulence Factor That Binds to Apolipoproteins A-I and A-II and Disrupts High Density Lipoprotein Structure. J. Biol. Chem. 281: 5515-5521 [Abstract] [Full Text]  
• Gupta, H., Dai, L., Datta, G., Garber, D. W., Grenett, H., Li, Y., Mishra, V., Palgunachari, M. N., Handattu, S., Gianturco, S. H., Bradley, W. A., Anantharamaiah, G.M., White, C. R. (2005). Inhibition of Lipopolysaccharide-Induced Inflammatory Responses by an Apolipoprotein AI Mimetic Peptide. Circ. Res. 97: 236-243 [Abstract] [Full Text]  
• Aspichueta, P., Perez, S., Ochoa, B., Fresnedo, O. (2005). Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver. J. Lipid Res. 46: 1017-1026 [Abstract] [Full Text]  
• Munford, R. S. (2005). Invited review: Detoxifying endotoxin: time, place and person. Innate Immunity 11: 69-84 [Abstract]  
• Berbee, J. F.P., Havekes, L. M., Rensen, P. C.N. (2005). Apolipoproteins modulate the inflammatory response to lipopolysaccharide. Innate Immunity 11: 97-103 [Abstract]  
• Stoll, L. L., Denning, G. M., Weintraub, N. L. (2004). Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 24: 2227-2236 [Abstract] [Full Text]  
• Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., Grunfeld, C. (2004). Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196 [Abstract] [Full Text]  
• Conraads, V. M., Bosmans, J. M., Schuerwegh, A. J., De Clerck, L. S., Bridts, C. H., Wuyts, F. L., Stevens, W. J., Vrints, C. J. (2003). Association of lipoproteins with cytokines and cytokine receptors in heart failure patients: Differences between ischaemic versus idiopathic cardiomyopathy. Eur Heart J 24: 2221-2226 [Abstract] [Full Text]  
• Kitchens, R. L., Thompson, P. A., Munford, R. S., O'Keefe, G. E. (2003). Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J. Lipid Res. 44: 2339-2348 [Abstract] [Full Text]  
• Liu, D., Cai, S., Gu, X., Scafidi, J., Wu, X., Davis, A. E. III (2003). C1 Inhibitor Prevents Endotoxin Shock Via a Direct Interaction with Lipopolysaccharide. J. Immunol. 171: 2594-2601 [Abstract] [Full Text]  
• Hudgins, L. C., Parker, T. S., Levine, D. M., Gordon, B. R., Saal, S. D., Jiang, X.-c., Seidman, C. E., Tremaroli, J. D., Lai, J., Rubin, A. L. (2003). A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J. Lipid Res. 44: 1489-1498 [Abstract] [Full Text]  
• Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]  
• Gordon, B. R, Parker, T. S, Levine, D. M, Saal, S. D, Hudgins, L. C., Sloan, B.-J., Chu, C., Stenzel, K. H, Rubin, A. L (2003). Safety and Pharmacokinetics of an Endotoxin-Binding Phospholipid Emulsion. The Annals of Pharmacotherapy 37: 943-950 [Abstract] [Full Text]  
• Vishnyakova, T. G., Bocharov, A. V., Baranova, I. N., Chen, Z., Remaley, A. T., Csako, G., Eggerman, T. L., Patterson, A. P. (2003). Binding and Internalization of Lipopolysaccharide by Cla-1, a Human Orthologue of Rodent Scavenger Receptor B1. J. Biol. Chem. 278: 22771-22780 [Abstract] [Full Text]  
• Rigotti, A., Miettinen, H. E., Krieger, M. (2003). The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues. Endocr. Rev. 24: 357-387 [Abstract] [Full Text]  
• Kitchens, R. L., Thompson, P. A. (2003). Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. Innate Immunity 9: 113-118 [Abstract]  
• Goldfarb, R. D., Parker, T. S., Levine, D. M., Glock, D., Akhter, I., Alkhudari, A., McCarthy, R. J., David, E. M., Gordon, B. R., Saal, S. D., Rubin, A. L., Trenholme, G. M., Parrillo, J. E. (2003). Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284: R550-R557 [Abstract] [Full Text]  
• Bennett-Guerrero, E., Feierman, D. E., Barclay, G. R., Parides, M. K., Sheiner, P. A., Mythen, M. G., Levine, D. M., Parker, T. S., Carroll, S. F., White, M. L., Winfree, W. J. (2001). Preoperative and Intraoperative Predictors of Postoperative Morbidity, Poor Graft Function, and Early Rejection in 190 Patients Undergoing Liver Transplantation. Arch Surg 136: 1177-1183 [Abstract] [Full Text]  
• Barlage, S., Fröhlich, D., Böttcher, A., Jauhiainen, M., Müller, H. P., Noetzel, F., Rothe, G., Schütt, C., Linke, R. P., Lackner, K. J., Ehnholm, C., Schmitz, G. (2001). ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J. Lipid Res. 42: 281-290 [Abstract] [Full Text]  
• Harris, H. W., Gosnell, J. E., Kumwenda, Z. L. (2000). Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity. Innate Immunity 6: 421-430 [Abstract]  
• Kitchens, R. L., Thompson, P. A., O'Keefe, G. E., Munford, R. S. (2000). Plasma constituents regulate LPS binding to, and release from, the monocyte cell surface. Innate Immunity 6: 477-482 [Abstract]  
• Vesy, C. J., Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (2000). Lipopolysaccharide-Binding Protein and Phospholipid Transfer Protein Release Lipopolysaccharides from Gram-Negative Bacterial Membranes. Infect. Immun. 68: 2410-2417 [Abstract] [Full Text]  
• Kitchens, R. L., Wolfbauer, G., Albers, J. J., Munford, R. S. (1999). Plasma Lipoproteins Promote the Release of Bacterial Lipopolysaccharide from the Monocyte Cell Surface. J. Biol. Chem. 274: 34116-34122 [Abstract] [Full Text]  
• de Haas, C. J. C., van der Zee, R., Benaissa-Trouw, B., van Kessel, K. P. M., Verhoef, J., van Strijp, J. A. G. (1999). Lipopolysaccharide (LPS)-Binding Synthetic Peptides Derived from Serum Amyloid P Component Neutralize LPS. Infect. Immun. 67: 2790-2796 [Abstract] [Full Text]  
• Azumi, S., Tanamoto, K.-i. (1999). Anti-endotoxin properties of a cinnamon bark-derived compound and its effect on the endotoxin shock model. Innate Immunity 5: 109-117 [Abstract]  
• de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., Stalenhoef, A. F. H. (1999). Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 40: 680-685 [Abstract] [Full Text]  
• de Haas, C. J. C., van der Tol, M. E., Van Kessel, K. P. M., Verhoef, J., Van Strijp, J. A. G. (1998). A Synthetic Lipopolysaccharide-Binding Peptide Based on Amino Acids 27-39 of Serum Amyloid P Component Inhibits Lipopolysaccharide-Induced Responses in Human Blood. J. Immunol. 161: 3607-3615 [Abstract] [Full Text]  
• Netea, M. G., de Bont, N., Demacker, P. N. M., Kullberg, B. J., Jacobs, L. E. H., Verver-Jansen, T. J. G., Stalenhoef, A. F. H., Van der Meer, J. W. M. (1998). Lipoprotein(a) Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Mononuclear Cells. Infect. Immun. 66: 2365-2367 [Abstract] [Full Text]  
• Lemaire, L.C.J.M., van der Poll, T., van Lanschot, J.J.B., Levels, H.M., van der Ende, B., van Deventer, S.J.H., Gouma, D.J. (1997). Human thoracic duct lymph inhibits lipopolysaccharide-induced release of cytokines. Innate Immunity 4: 331-338 [Abstract]  
• Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Breve, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., Kuiper, J. (2001). Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality. A NEW THERAPEUTIC APPROACH TO TREAT GRAM-NEGATIVE SEPSIS. J. Biol. Chem. 276: 8820-8824 [Abstract] [Full Text]